Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q88755007
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010858.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q88755007
|
024
|
|
|
‡a
0000-0002-0428-0199
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q88755007
|
100
|
0 |
|
‡a
Sebastian Fernandez-Pol
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Sebastian Fernandez-Pol
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations
|
670
|
|
|
‡a
Author's Differentiation syndrome during ivosidenib treatment with immunohistochemistry showing isocitrate dehydrogenase R132H mutation
|
670
|
|
|
‡a
Author's DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
|
670
|
|
|
‡a
Author's Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens
|
670
|
|
|
‡a
Author's Immunohistochemistry reveals an increased proportion of MYC-positive cells in subcutaneous panniculitis-like T-cell lymphoma compared with lupus panniculitis.
|
670
|
|
|
‡a
Author's Reticulohistiocytoma (solitary epithelioid histiocytoma) with mutations in RAF1 and TSC2
|
909
|
|
|
‡a
(orcid) 0000000204280199
‡9
1
|
919
|
|
|
‡a
differentiationsyndromeduringivosidenibtreatmentwithimmunohistochemistryshowingisocitratedehydrogenaser132hmutation
‡A
Differentiation syndrome during ivosidenib treatment with immunohistochemistry showing isocitrate dehydrogenase R132H mutation
‡9
1
|
919
|
|
|
‡a
dlbclmorphmorphologicalfeaturescomputedusingdeeplearningforanannotateddigitaldlbclimageset
‡A
DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
‡9
1
|
919
|
|
|
‡a
immunohistochemistryforpax7isausefulconfirmatorymarkerforewingsarcomaindecalcifiedbonemarrowcorebiopsyspecimens
‡A
Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens
‡9
1
|
919
|
|
|
‡a
immunohistochemistryrevealsanincreasedproportionofmycpositivecellsinsubcutaneouspanniculitisliketcelllymphomacomparedwithlupuspanniculitis
‡A
Immunohistochemistry reveals an increased proportion of MYC-positive cells in subcutaneous panniculitis-like T-cell lymphoma compared with lupus panniculitis.
‡9
1
|
919
|
|
|
‡a
reticulohistiocytomasolitaryepithelioidhistiocytomawithmutationsinraf1andtsc2
‡A
Reticulohistiocytoma (solitary epithelioid histiocytoma) with mutations in RAF1 and TSC2
‡9
1
|
919
|
|
|
‡a
cutaneouspleomorphicfibromasarisinginpatientswithgermlinetp53mutations
‡A
Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations
‡9
1
|
996
|
|
|
‡2
ISNI|0000000391375096
|
996
|
|
|
‡2
ISNI|000000039225371X
|
996
|
|
|
‡2
CAOONL|ncf10911512
|
996
|
|
|
‡2
LC|n 97071210
|
996
|
|
|
‡2
B2Q|0000353362
|
996
|
|
|
‡2
NTA|326837213
|
996
|
|
|
‡2
PLWABN|9810646439905606
|
996
|
|
|
‡2
ISNI|0000000109014044
|
996
|
|
|
‡2
LC|n 2020044070
|
996
|
|
|
‡2
NTA|142763578
|
996
|
|
|
‡2
CAOONL|ncf11247372
|
996
|
|
|
‡2
SUDOC|228314593
|
996
|
|
|
‡2
LC|n 2005210788
|
996
|
|
|
‡2
ISNI|0000000048325980
|
996
|
|
|
‡2
NTA|11528155X
|
996
|
|
|
‡2
NSK|000380970
|
996
|
|
|
‡2
NII|DA14326378
|
996
|
|
|
‡2
ISNI|0000000451511345
|
996
|
|
|
‡2
ISNI|0000000045313116
|
996
|
|
|
‡2
DE633|pe41022132
|
996
|
|
|
‡2
NTA|07277181X
|
996
|
|
|
‡2
DNB|130360627
|
996
|
|
|
‡2
NUKAT|n 97090634
|
996
|
|
|
‡2
DNB|100321704
|
996
|
|
|
‡2
NKC|pna20221140221
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|